[email protected]/(408) 457-3700

Company Overview

About HealthUp

Worldwide there are 300 million people suffering from asthma and 210 million people suffering from chronic obstructive pulmonary disease. 50% of them are not diagnosed partly due to the lack of easily available spirometry – the basic test of airways condition. Those diagnosed often have poor control of the disease which leads to exacerbations and hospitalizations. MySpiroo is a solution to these problems. The device is paired with a mobile application for iOS and Android, allowing users to have an in-home spirometer at their disposal, tracking their results and enabling them to eliminate severe hospitalizations due to acute and chronic exacerbations.

Technology Overview

MySpiroo is more than just a spirometer, the device measures and records respiratory (FVC, FEV1, FEV1/FEV6, FEV1%, PEF, FEF25-75, etc.), cardiovascular (heart rate, pulse oximetry SpO2) and environmental parameters (temperature, atmospheric pressure, humidity), all of which influence the lung functions of asthma and COPD patients. The device works with a dedicated smartphone application for both patients and health care providers.

You need to register as an accredited investor before we can show you the details of any investment opportunities.

VentureHealth is currently invite only.

Request An Invite!

Startup's Info

Location:
Warsawa, Poland
Markets:
Medical Devices, Digital Health
Therapeutic Areas:
Pulmonary / Respiratory Diseases